Position in FATE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,186,057
+$1,790,605 QoQ
Shares Held
1,821,715
+351.5% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9835320014382.ToString("F0")%
Shared 0.ToString("F0")%
None 0.016467998561794792.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. FATE ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,186,057 | 1,821,715 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $395,452 | 403,524 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $396,595 | 314,759 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,078,192 | 962,672 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,225,353 | 1,551,081 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,820,597 | 1,103,393 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,414,976 | 404,279 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $539,087 | 164,356 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,259,326 | 444,050 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $659,380 | 176,305 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $141,424 | 66,710 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,236,104 | 259,686 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,383,317 | 418,126 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,945,381 | 291,911 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $52,999 | 2,365 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,300,651 | 52,488 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,408,918 | 139,513 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,489,278 | 128,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,569,765 | 26,485 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,354,617 | 15,608 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,709,919 | 44,996 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,976,470 | 87,721 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $276,912 | 6,928 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $178,789 | 5,211 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $156,313 | 7,038 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||